| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |